HEADER HYDROLASE 10-NOV-23 8R41 TITLE STRUCTURE OF CHI3L1 IN COMPLEX WITH INHIBITOR 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITINASE-3-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: COMPND 6 MGVKASQTGFVVLVLLQCCSAYKLVCYYTSWSQYREGDGSCFPDALDRFLCTHIIYSFAN COMPND 7 ISNDHIDTWEWNDVTLYGMLNTLKNRNPNLKTLLSVGGWNFGSQRFSKIASNTQSRRTFI COMPND 8 KSVPPFLRTHGFDGLDLAWLYPGRRDKQHFTTLIKEMKAEFIKEAQPGKKQLLLSAALSA COMPND 9 GKVTIDSSYDIAKISQHLDFISIMTYDFHGAWRGTTGHHSPLFRGQEDASPDRFSNTDYA COMPND 10 VGYMLRLGAPASKLVMGIPTFGRSFTLASSETGVGAPISGPGIPGRFTKEAGTLAYYEIC COMPND 11 DFLRGATVHRILGQQVPYATKGNQWVGYDDQESVKSKVQYLKDRQLAGAMVWALDLDDFQ COMPND 12 GSFCGQDLRFPLTNAIKDALAAT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHI3L1; SOURCE 6 EXPRESSION_SYSTEM: MAMMALIA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 40674; SOURCE 8 EXPRESSION_SYSTEM_CELL: HEK293 KEYWDS CHITINASE-3-LIKE-1, INHIBITORS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.NOWAK,A.NAPIORKOWSKA-GROMADZKA,M.NOWOTNY REVDAT 2 27-MAR-24 8R41 1 JRNL REVDAT 1 13-MAR-24 8R41 0 JRNL AUTH W.CZESTKOWSKI,L.KRZEMINSKI,M.C.PIOTROWICZ,M.MAZUR,E.PLUTA, JRNL AUTH 2 G.ANDRYIANAU,R.KORALEWSKI,K.MATYSZEWSKI,S.OLEJNICZAK, JRNL AUTH 3 M.KOWALSKI,K.LISIECKA,R.KOZIEL,K.PIWOWAR,D.PAPIERNIK, JRNL AUTH 4 M.NOWOTNY,A.NAPIORKOWSKA-GROMADZKA,E.NOWAK,D.NIEDZIALEK, JRNL AUTH 5 G.WIECZOREK,A.SIWINSKA,T.REJCZAK,K.JEDRZEJCZAK,K.MULEWSKI, JRNL AUTH 6 J.OLCZAK,Z.ZASLONA,A.GOLEBIOWSKI,K.DRZEWICKA,A.BARTOSZEWICZ JRNL TITL STRUCTURE-BASED DISCOVERY OF HIGH-AFFINITY SMALL MOLECULE JRNL TITL 2 LIGANDS AND DEVELOPMENT OF TOOL PROBES TO STUDY THE ROLE OF JRNL TITL 3 CHITINASE-3-LIKE PROTEIN 1. JRNL REF J.MED.CHEM. V. 67 3959 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38427954 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02255 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.19.2_4158: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 43005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 2100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5700 - 5.5500 0.98 2870 148 0.1845 0.1986 REMARK 3 2 5.5500 - 4.4000 0.98 2767 142 0.1617 0.1700 REMARK 3 3 4.4000 - 3.8500 0.99 2783 143 0.1635 0.2019 REMARK 3 4 3.8500 - 3.5000 0.98 2713 139 0.1980 0.2452 REMARK 3 5 3.5000 - 3.2400 0.99 2740 141 0.2181 0.2392 REMARK 3 6 3.2400 - 3.0500 0.99 2729 140 0.2392 0.3141 REMARK 3 7 3.0500 - 2.9000 0.99 2745 141 0.2600 0.2955 REMARK 3 8 2.9000 - 2.7700 0.98 2702 138 0.2429 0.2599 REMARK 3 9 2.7700 - 2.6700 0.99 2692 139 0.2421 0.2909 REMARK 3 10 2.6700 - 2.5800 0.98 2717 139 0.2570 0.2933 REMARK 3 11 2.5800 - 2.4900 0.98 2715 139 0.2748 0.3074 REMARK 3 12 2.4900 - 2.4200 0.98 2684 138 0.2920 0.3412 REMARK 3 13 2.4200 - 2.3600 0.98 2683 138 0.3014 0.3132 REMARK 3 14 2.3600 - 2.3000 0.98 2705 139 0.3039 0.3489 REMARK 3 15 2.3000 - 2.2500 0.96 2660 136 0.3041 0.3361 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 5780 REMARK 3 ANGLE : 0.655 7843 REMARK 3 CHIRALITY : 0.044 855 REMARK 3 PLANARITY : 0.006 998 REMARK 3 DIHEDRAL : 16.180 859 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -40.6214 -10.5319 20.6616 REMARK 3 T TENSOR REMARK 3 T11: 0.4133 T22: 0.4396 REMARK 3 T33: 0.3797 T12: 0.0142 REMARK 3 T13: -0.0274 T23: -0.0218 REMARK 3 L TENSOR REMARK 3 L11: 0.7842 L22: 1.1301 REMARK 3 L33: 0.5647 L12: -0.4712 REMARK 3 L13: 0.5420 L23: -0.4231 REMARK 3 S TENSOR REMARK 3 S11: -0.0620 S12: 0.0977 S13: -0.1461 REMARK 3 S21: -0.0654 S22: 0.0353 S23: 0.1225 REMARK 3 S31: -0.0365 S32: -0.0169 S33: -0.0170 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8R41 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-NOV-23. REMARK 100 THE DEPOSITION ID IS D_1292134589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43020 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 49.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% (V/W) PEG 4000, 0.1 M SODIUM REMARK 280 CITRATE PH 4.6, 0.2 M AMMONIUM SULFATE AND 0.1 M DTT, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 54.68000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.36500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.12500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.36500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 54.68000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.12500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 54.68000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.12500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 68.36500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.12500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 54.68000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 68.36500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, Y REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 BR BR A 406 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 555 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 VAL A 3 REMARK 465 LYS A 4 REMARK 465 ALA A 5 REMARK 465 SER A 6 REMARK 465 GLN A 7 REMARK 465 THR A 8 REMARK 465 GLY A 9 REMARK 465 PHE A 10 REMARK 465 VAL A 11 REMARK 465 VAL A 12 REMARK 465 LEU A 13 REMARK 465 VAL A 14 REMARK 465 LEU A 15 REMARK 465 LEU A 16 REMARK 465 GLN A 17 REMARK 465 CYS A 18 REMARK 465 CYS A 19 REMARK 465 SER A 20 REMARK 465 ALA A 21 REMARK 465 CYS A 364 REMARK 465 GLY A 365 REMARK 465 GLN A 366 REMARK 465 ASP A 367 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 VAL B 3 REMARK 465 LYS B 4 REMARK 465 ALA B 5 REMARK 465 SER B 6 REMARK 465 GLN B 7 REMARK 465 THR B 8 REMARK 465 GLY B 9 REMARK 465 PHE B 10 REMARK 465 VAL B 11 REMARK 465 VAL B 12 REMARK 465 LEU B 13 REMARK 465 VAL B 14 REMARK 465 LEU B 15 REMARK 465 LEU B 16 REMARK 465 GLN B 17 REMARK 465 CYS B 18 REMARK 465 CYS B 19 REMARK 465 SER B 20 REMARK 465 ALA B 21 REMARK 465 PHE B 363 REMARK 465 CYS B 364 REMARK 465 GLY B 365 REMARK 465 GLN B 366 REMARK 465 ASP B 367 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 86 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 89 CG OD1 ND2 REMARK 470 LYS A 91 CE NZ REMARK 470 GLN A 104 CG CD OE1 NE2 REMARK 470 LYS A 108 CG CD CE NZ REMARK 470 GLN A 114 CG CD OE1 NE2 REMARK 470 GLN A 148 CG CD OE1 NE2 REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 LYS A 163 CG CD CE NZ REMARK 470 LYS A 170 CG CD CE NZ REMARK 470 ARG A 213 CZ NH1 NH2 REMARK 470 ARG A 286 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 304 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 335 CG CD CE NZ REMARK 470 LEU A 368 CG CD1 CD2 REMARK 470 ASN B 63 CG OD1 ND2 REMARK 470 ARG B 86 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 91 CE NZ REMARK 470 ASN B 100 CG OD1 ND2 REMARK 470 GLN B 104 CG CD OE1 NE2 REMARK 470 SER B 107 OG REMARK 470 LYS B 108 CG CD CE NZ REMARK 470 ILE B 109 CG1 CG2 CD1 REMARK 470 GLN B 114 CG CD OE1 NE2 REMARK 470 ARG B 117 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 121 CG CD CE NZ REMARK 470 ARG B 144 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 145 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 148 CG CD OE1 NE2 REMARK 470 LYS B 155 CG CD CE NZ REMARK 470 ILE B 162 CG1 CG2 CD1 REMARK 470 LYS B 163 CG CD CE NZ REMARK 470 LYS B 169 CE NZ REMARK 470 LYS B 170 CG CD CE NZ REMARK 470 LYS B 193 CG CD CE NZ REMARK 470 ARG B 213 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 286 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 304 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 335 CG CD CE NZ REMARK 470 LEU B 368 CG CD1 CD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 91 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU B 267 O2 EDO B 406 2.09 REMARK 500 O THR B 29 OG SER B 32 2.16 REMARK 500 O ILE B 191 OG SER B 195 2.17 REMARK 500 O HOH A 516 O HOH A 570 2.18 REMARK 500 O HOH A 564 O HOH A 583 2.19 REMARK 500 O HOH B 529 O HOH B 549 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 103 -43.80 63.08 REMARK 500 PRO A 167 70.47 -69.02 REMARK 500 HIS A 209 57.41 -92.86 REMARK 500 SER A 220 59.02 -141.96 REMARK 500 SER A 235 49.48 -90.96 REMARK 500 TRP B 69 -58.78 -120.30 REMARK 500 SER B 103 -54.45 60.90 REMARK 500 LYS B 321 119.46 -161.54 REMARK 500 REMARK 500 REMARK: NULL DBREF 8R41 A 1 383 UNP P36222 CH3L1_HUMAN 1 383 DBREF 8R41 B 1 383 UNP P36222 CH3L1_HUMAN 1 383 SEQRES 1 A 383 MET GLY VAL LYS ALA SER GLN THR GLY PHE VAL VAL LEU SEQRES 2 A 383 VAL LEU LEU GLN CYS CYS SER ALA TYR LYS LEU VAL CYS SEQRES 3 A 383 TYR TYR THR SER TRP SER GLN TYR ARG GLU GLY ASP GLY SEQRES 4 A 383 SER CYS PHE PRO ASP ALA LEU ASP ARG PHE LEU CYS THR SEQRES 5 A 383 HIS ILE ILE TYR SER PHE ALA ASN ILE SER ASN ASP HIS SEQRES 6 A 383 ILE ASP THR TRP GLU TRP ASN ASP VAL THR LEU TYR GLY SEQRES 7 A 383 MET LEU ASN THR LEU LYS ASN ARG ASN PRO ASN LEU LYS SEQRES 8 A 383 THR LEU LEU SER VAL GLY GLY TRP ASN PHE GLY SER GLN SEQRES 9 A 383 ARG PHE SER LYS ILE ALA SER ASN THR GLN SER ARG ARG SEQRES 10 A 383 THR PHE ILE LYS SER VAL PRO PRO PHE LEU ARG THR HIS SEQRES 11 A 383 GLY PHE ASP GLY LEU ASP LEU ALA TRP LEU TYR PRO GLY SEQRES 12 A 383 ARG ARG ASP LYS GLN HIS PHE THR THR LEU ILE LYS GLU SEQRES 13 A 383 MET LYS ALA GLU PHE ILE LYS GLU ALA GLN PRO GLY LYS SEQRES 14 A 383 LYS GLN LEU LEU LEU SER ALA ALA LEU SER ALA GLY LYS SEQRES 15 A 383 VAL THR ILE ASP SER SER TYR ASP ILE ALA LYS ILE SER SEQRES 16 A 383 GLN HIS LEU ASP PHE ILE SER ILE MET THR TYR ASP PHE SEQRES 17 A 383 HIS GLY ALA TRP ARG GLY THR THR GLY HIS HIS SER PRO SEQRES 18 A 383 LEU PHE ARG GLY GLN GLU ASP ALA SER PRO ASP ARG PHE SEQRES 19 A 383 SER ASN THR ASP TYR ALA VAL GLY TYR MET LEU ARG LEU SEQRES 20 A 383 GLY ALA PRO ALA SER LYS LEU VAL MET GLY ILE PRO THR SEQRES 21 A 383 PHE GLY ARG SER PHE THR LEU ALA SER SER GLU THR GLY SEQRES 22 A 383 VAL GLY ALA PRO ILE SER GLY PRO GLY ILE PRO GLY ARG SEQRES 23 A 383 PHE THR LYS GLU ALA GLY THR LEU ALA TYR TYR GLU ILE SEQRES 24 A 383 CYS ASP PHE LEU ARG GLY ALA THR VAL HIS ARG ILE LEU SEQRES 25 A 383 GLY GLN GLN VAL PRO TYR ALA THR LYS GLY ASN GLN TRP SEQRES 26 A 383 VAL GLY TYR ASP ASP GLN GLU SER VAL LYS SER LYS VAL SEQRES 27 A 383 GLN TYR LEU LYS ASP ARG GLN LEU ALA GLY ALA MET VAL SEQRES 28 A 383 TRP ALA LEU ASP LEU ASP ASP PHE GLN GLY SER PHE CYS SEQRES 29 A 383 GLY GLN ASP LEU ARG PHE PRO LEU THR ASN ALA ILE LYS SEQRES 30 A 383 ASP ALA LEU ALA ALA THR SEQRES 1 B 383 MET GLY VAL LYS ALA SER GLN THR GLY PHE VAL VAL LEU SEQRES 2 B 383 VAL LEU LEU GLN CYS CYS SER ALA TYR LYS LEU VAL CYS SEQRES 3 B 383 TYR TYR THR SER TRP SER GLN TYR ARG GLU GLY ASP GLY SEQRES 4 B 383 SER CYS PHE PRO ASP ALA LEU ASP ARG PHE LEU CYS THR SEQRES 5 B 383 HIS ILE ILE TYR SER PHE ALA ASN ILE SER ASN ASP HIS SEQRES 6 B 383 ILE ASP THR TRP GLU TRP ASN ASP VAL THR LEU TYR GLY SEQRES 7 B 383 MET LEU ASN THR LEU LYS ASN ARG ASN PRO ASN LEU LYS SEQRES 8 B 383 THR LEU LEU SER VAL GLY GLY TRP ASN PHE GLY SER GLN SEQRES 9 B 383 ARG PHE SER LYS ILE ALA SER ASN THR GLN SER ARG ARG SEQRES 10 B 383 THR PHE ILE LYS SER VAL PRO PRO PHE LEU ARG THR HIS SEQRES 11 B 383 GLY PHE ASP GLY LEU ASP LEU ALA TRP LEU TYR PRO GLY SEQRES 12 B 383 ARG ARG ASP LYS GLN HIS PHE THR THR LEU ILE LYS GLU SEQRES 13 B 383 MET LYS ALA GLU PHE ILE LYS GLU ALA GLN PRO GLY LYS SEQRES 14 B 383 LYS GLN LEU LEU LEU SER ALA ALA LEU SER ALA GLY LYS SEQRES 15 B 383 VAL THR ILE ASP SER SER TYR ASP ILE ALA LYS ILE SER SEQRES 16 B 383 GLN HIS LEU ASP PHE ILE SER ILE MET THR TYR ASP PHE SEQRES 17 B 383 HIS GLY ALA TRP ARG GLY THR THR GLY HIS HIS SER PRO SEQRES 18 B 383 LEU PHE ARG GLY GLN GLU ASP ALA SER PRO ASP ARG PHE SEQRES 19 B 383 SER ASN THR ASP TYR ALA VAL GLY TYR MET LEU ARG LEU SEQRES 20 B 383 GLY ALA PRO ALA SER LYS LEU VAL MET GLY ILE PRO THR SEQRES 21 B 383 PHE GLY ARG SER PHE THR LEU ALA SER SER GLU THR GLY SEQRES 22 B 383 VAL GLY ALA PRO ILE SER GLY PRO GLY ILE PRO GLY ARG SEQRES 23 B 383 PHE THR LYS GLU ALA GLY THR LEU ALA TYR TYR GLU ILE SEQRES 24 B 383 CYS ASP PHE LEU ARG GLY ALA THR VAL HIS ARG ILE LEU SEQRES 25 B 383 GLY GLN GLN VAL PRO TYR ALA THR LYS GLY ASN GLN TRP SEQRES 26 B 383 VAL GLY TYR ASP ASP GLN GLU SER VAL LYS SER LYS VAL SEQRES 27 B 383 GLN TYR LEU LYS ASP ARG GLN LEU ALA GLY ALA MET VAL SEQRES 28 B 383 TRP ALA LEU ASP LEU ASP ASP PHE GLN GLY SER PHE CYS SEQRES 29 B 383 GLY GLN ASP LEU ARG PHE PRO LEU THR ASN ALA ILE LYS SEQRES 30 B 383 ASP ALA LEU ALA ALA THR HET NAG X 1 14 HET NAG X 2 14 HET NAG Y 1 14 HET NAG Y 2 14 HET XUF A 401 25 HET EDO A 402 4 HET EDO A 403 4 HET EDO A 404 4 HET EDO A 405 4 HET BR A 406 1 HET BR A 407 1 HET XUF B 401 25 HET EDO B 402 4 HET EDO B 403 4 HET EDO B 404 4 HET EDO B 405 4 HET EDO B 406 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM XUF ~{N}-[2-(4-BROMOPHENYL)ETHYL]-~{N}-(2-METHOXYETHYL)-1- HETNAM 2 XUF (1,3-THIAZOL-2-YL)PIPERIDIN-4-AMINE HETNAM EDO 1,2-ETHANEDIOL HETNAM BR BROMIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 5 XUF 2(C19 H26 BR N3 O S) FORMUL 6 EDO 9(C2 H6 O2) FORMUL 10 BR 2(BR 1-) FORMUL 18 HOH *164(H2 O) HELIX 1 AA1 TRP A 31 ARG A 35 5 5 HELIX 2 AA2 GLU A 36 SER A 40 5 5 HELIX 3 AA3 PHE A 42 LEU A 46 5 5 HELIX 4 AA4 ASN A 72 LEU A 83 1 12 HELIX 5 AA5 SER A 103 ASN A 112 1 10 HELIX 6 AA6 ASN A 112 GLY A 131 1 20 HELIX 7 AA7 PRO A 142 GLN A 166 1 25 HELIX 8 AA8 GLY A 181 TYR A 189 1 9 HELIX 9 AA9 ASP A 190 LEU A 198 1 9 HELIX 10 AB1 GLN A 226 SER A 230 5 5 HELIX 11 AB2 ASN A 236 LEU A 247 1 12 HELIX 12 AB3 PRO A 250 SER A 252 5 3 HELIX 13 AB4 TYR A 296 ARG A 304 1 9 HELIX 14 AB5 ASP A 330 ARG A 344 1 15 HELIX 15 AB6 ALA A 353 ASP A 357 5 5 HELIX 16 AB7 PHE A 370 ALA A 381 1 12 HELIX 17 AB8 TRP B 31 ARG B 35 5 5 HELIX 18 AB9 GLU B 36 SER B 40 5 5 HELIX 19 AC1 PHE B 42 LEU B 46 5 5 HELIX 20 AC2 ASN B 72 THR B 82 1 11 HELIX 21 AC3 LEU B 83 ARG B 86 5 4 HELIX 22 AC4 SER B 103 ASN B 112 1 10 HELIX 23 AC5 ASN B 112 GLY B 131 1 20 HELIX 24 AC6 ASP B 146 ALA B 165 1 20 HELIX 25 AC7 GLY B 181 TYR B 189 1 9 HELIX 26 AC8 ASP B 190 LEU B 198 1 9 HELIX 27 AC9 GLN B 226 SER B 230 5 5 HELIX 28 AD1 ASN B 236 LEU B 247 1 12 HELIX 29 AD2 PRO B 250 SER B 252 5 3 HELIX 30 AD3 TYR B 296 LEU B 303 1 8 HELIX 31 AD4 ASP B 330 ARG B 344 1 15 HELIX 32 AD5 ALA B 353 ASP B 357 5 5 HELIX 33 AD6 PHE B 370 ALA B 381 1 12 SHEET 1 AA110 HIS A 65 ASP A 67 0 SHEET 2 AA110 HIS A 53 SER A 62 -1 N SER A 62 O HIS A 65 SHEET 3 AA110 LYS A 91 GLY A 98 1 O SER A 95 N TYR A 56 SHEET 4 AA110 GLY A 134 TRP A 139 1 O ALA A 138 N VAL A 96 SHEET 5 AA110 LEU A 173 SER A 179 1 O LEU A 173 N LEU A 135 SHEET 6 AA110 PHE A 200 MET A 204 1 O MET A 204 N LEU A 178 SHEET 7 AA110 LEU A 254 PRO A 259 1 O VAL A 255 N ILE A 201 SHEET 8 AA110 GLY A 348 TRP A 352 1 O MET A 350 N ILE A 258 SHEET 9 AA110 LYS A 23 THR A 29 1 N VAL A 25 O VAL A 351 SHEET 10 AA110 HIS A 53 SER A 62 1 O ILE A 55 N TYR A 28 SHEET 1 AA2 3 ILE A 278 PRO A 281 0 SHEET 2 AA2 3 PHE A 261 LEU A 267 -1 N THR A 266 O GLY A 280 SHEET 3 AA2 3 THR A 293 ALA A 295 -1 O LEU A 294 N GLY A 262 SHEET 1 AA3 5 ILE A 278 PRO A 281 0 SHEET 2 AA3 5 PHE A 261 LEU A 267 -1 N THR A 266 O GLY A 280 SHEET 3 AA3 5 GLN A 324 GLY A 327 -1 O TRP A 325 N PHE A 265 SHEET 4 AA3 5 VAL A 316 LYS A 321 -1 N ALA A 319 O VAL A 326 SHEET 5 AA3 5 THR A 307 ILE A 311 -1 N ILE A 311 O VAL A 316 SHEET 1 AA410 HIS B 65 ASP B 67 0 SHEET 2 AA410 HIS B 53 SER B 62 -1 N SER B 62 O HIS B 65 SHEET 3 AA410 LYS B 91 GLY B 98 1 O SER B 95 N TYR B 56 SHEET 4 AA410 GLY B 134 TRP B 139 1 O ALA B 138 N VAL B 96 SHEET 5 AA410 LEU B 173 SER B 179 1 O SER B 175 N LEU B 137 SHEET 6 AA410 PHE B 200 MET B 204 1 O MET B 204 N LEU B 178 SHEET 7 AA410 LEU B 254 PRO B 259 1 O VAL B 255 N ILE B 203 SHEET 8 AA410 GLY B 348 TRP B 352 1 O MET B 350 N MET B 256 SHEET 9 AA410 LYS B 23 THR B 29 1 N VAL B 25 O VAL B 351 SHEET 10 AA410 HIS B 53 SER B 62 1 O ILE B 55 N TYR B 28 SHEET 1 AA5 3 ILE B 278 PRO B 281 0 SHEET 2 AA5 3 PHE B 261 LEU B 267 -1 N THR B 266 O GLY B 280 SHEET 3 AA5 3 THR B 293 ALA B 295 -1 O LEU B 294 N GLY B 262 SHEET 1 AA6 5 ILE B 278 PRO B 281 0 SHEET 2 AA6 5 PHE B 261 LEU B 267 -1 N THR B 266 O GLY B 280 SHEET 3 AA6 5 GLN B 324 GLY B 327 -1 O GLY B 327 N ARG B 263 SHEET 4 AA6 5 VAL B 316 LYS B 321 -1 N ALA B 319 O VAL B 326 SHEET 5 AA6 5 THR B 307 ILE B 311 -1 N HIS B 309 O TYR B 318 SSBOND 1 CYS A 26 CYS A 51 1555 1555 2.03 SSBOND 2 CYS B 26 CYS B 51 1555 1555 2.03 LINK ND2 ASN A 60 C1 NAG X 1 1555 1555 1.44 LINK ND2 ASN B 60 C1 NAG Y 1 1555 1555 1.44 LINK O4 NAG X 1 C1 NAG X 2 1555 1555 1.44 LINK O4 NAG Y 1 C1 NAG Y 2 1555 1555 1.44 CISPEP 1 SER A 57 PHE A 58 0 -4.73 CISPEP 2 LEU A 140 TYR A 141 0 -0.87 CISPEP 3 TRP A 352 ALA A 353 0 -0.84 CISPEP 4 SER B 57 PHE B 58 0 -2.37 CISPEP 5 LEU B 140 TYR B 141 0 -6.04 CISPEP 6 TRP B 352 ALA B 353 0 -3.88 CRYST1 109.360 122.250 136.730 90.00 90.00 90.00 I 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009144 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007314 0.00000